-
A648503-25mgALM301 is an orally active highly specific AKT inhibitor with IC 50 values of 0.13 µM, 0.09 µM and 2.75 µM for AKT1 , AKT2 and AKT3 , respectively. ALM301 inhibits AKT phosphorylation and modulates downstream signalling in vitro . ALM301 can inhibit
-
A648503-5mgALM301 is an orally active highly specific AKT inhibitor with IC 50 values of 0.13 µM, 0.09 µM and 2.75 µM for AKT1 , AKT2 and AKT3 , respectively. ALM301 inhibits AKT phosphorylation and modulates downstream signalling in vitro . ALM301 can inhibit
-
A655455-1mlALM301 is an orally active highly specific AKT inhibitor with IC 50 values of 0.13 µM, 0.09 µM and 2.75 µM for AKT1 , AKT2 and AKT3 , respectively. ALM301 inhibits AKT phosphorylation and modulates downstream signalling in vitro . ALM301 can inhibit
-
A129703-10mgAlmotriptan Malate is a selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist, used for the treatment of Migraine attacks in adultsA serotonin 5HT1B /1D-receptor agonist used for treatment of migraines.
-
A129703-1gAlmotriptan Malate is a selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist, used for the treatment of Migraine attacks in adultsA serotonin 5HT1B /1D-receptor agonist used for treatment of migraines.
-
A129703-250mgAlmotriptan Malate is a selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist, used for the treatment of Migraine attacks in adultsA serotonin 5HT1B /1D-receptor agonist used for treatment of migraines.
-
A129703-50mgAlmotriptan Malate is a selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist, used for the treatment of Migraine attacks in adultsA serotonin 5HT1B /1D-receptor agonist used for treatment of migraines.
-
A111278-100mgApoptotic and anticancer agent.
-
A111278-1gApoptotic and anticancer agent.
-
A111278-250mgApoptotic and anticancer agent.
-
A111278-25gApoptotic and anticancer agent.
-
A111278-25mgApoptotic and anticancer agent.